TENGION INC has a total of 73 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Canada. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are MESYNTHES LTD, ATRM LLC and NOVAHEP AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 13 | |
#2 | China | 12 | |
#3 | Canada | 10 | |
#4 | New Zealand | 8 | |
#5 | EPO (European Patent Office) | 7 | |
#6 | Japan | 7 | |
#7 | Republic of Korea | 7 | |
#8 | Hong Kong | 4 | |
#9 | United States | 3 | |
#10 | Australia | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Macromolecular chemistry and polymers | |
#6 | Surface technology and coating | |
#7 | Textiles and paper | |
#8 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Bertram Timothy A | 37 |
#2 | Jain Deepak | 35 |
#3 | Jayo Manuel J | 35 |
#4 | Ilagan Roger M | 34 |
#5 | Ludlow John W | 31 |
#6 | Guthrie Kelly I | 31 |
#7 | Payne Richard | 31 |
#8 | Rapoport H Scott | 30 |
#9 | Basu Joydeep | 30 |
#10 | Bruce Andrew | 24 |
Publication | Filing date | Title |
---|---|---|
US2014308695A1 | Drug screening and potency assays | |
TW201211256A | Erythropoietin-expressing adipose cell populations | |
WO2011156642A1 | Erythropoietin-expressing adipose cell populations | |
CA2797705A1 | Smooth muscle cell constructs | |
CA2791736A1 | Cell-scaffold constructs | |
CN102006837A | Tissue engineering scaffolds | |
CA2641733A1 | Scaffolds for organ reconstruction and augmentation |